EUVIMEDEUVIMED entdecken
Crossref

Role of A 2A R-D2R Dimerization and D 2 R-Biased Signaling in PDE10A-Mediated Cardiac Hypertrophy

Si Chen iD, Xinyue Fan, Sumin Xu, Nichen Zhu, Hangchuan Shi iD, Zheng Gen Jin iD, Chen Yan iD

Circulation · 2025

DOI: 10.1161/circulationaha.125.075465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2025. Verfasst von Si Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine (S.C., X.F., S.X., N.Z., Z.J., C.Y.), University of Rochester School of Medicine and Dentistry, Rochester, NY. Hauptthemen laut MEDLINE: Phosphoric Diester Hydrolases, Myocytes, Cardiac, Cardiomegaly, Receptors, Dopamine D2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pathological cardiomyocyte (CM) hypertrophy is a hallmark of dilated cardiomyopathy and heart failure, driven by mechanical or neurohumoral stress. Although we previously demonstrated PDE10A (phosphodiesterase 10A) as a critical contributor and potential therapeutic target in pathological cardiac remodeling and dysfunction, the underlying mechanisms remain unclear. Here, we investigated the specific signaling pathways and sources of cyclic nucleotides modulated by PDE10A in CM hypertrophy. METHODS: CM hypertrophy was induced by angiotensin II in isolated adult mouse CMs, with hypertrophy assessed by cell surface area and protein synthesis. PDE10A inactivation was achieved through PDE10A knockout or inhibition with TP-10. Various pharmacological agonists/antagonists, genetic mutants, and knockout models of D 2 R (dopamine receptor D2) and A 2A R (adenosine A 2A receptor) were used to study the role of A 2A R-D 2 R heterodimer and downstream signaling in CM hypertrophy in vitro and in vivo. Viral vectors were used to manipulate protein or small hairpin RNA expression targeting key signaling molecules. RESULTS: We demonstrated that the antihypertrophic effect of PDE10A inactivation is specifically dependent on cAMP/PKA (protein kinase A) signaling. Importantly, we discovered an A 2A R-D 2 R heterodimer and its association with PDE10A in CMs. The A 2A R-D 2 R heterodimer mediates the βarr2 (beta-arrestin 2)–biased D 2 R signaling, and activating D 2 R-biased signaling antagonizes cardiac hypertrophy and dysfunction. PDE10A deficiency or inhibition enhanced A 2A R-D 2 R heterodimerization, promoting βarr2-biased D 2 R signaling and downstream PP2A (protein phosphatase 2A)-B56δ activation through increased A 2A R/cAMP/PKA–mediated D 2 R phosphorylation. PDE10A inactivation inhibits stress signal–induced HDAC5 (histone deacetylase 5) nuclear export and phosphorylation, which are dependent on PP2A. Genetic and pharmacological approaches in animal models confirmed the critical roles of A 2A R-D 2 R heterodimerization, D 2 R phosphorylation, and biased D 2 R signaling in vivo. Furthermore, combining PDE10A inhibition with A 2A R or D 2 R-biased agonism produced synergistic antihypertrophic effects, highlighting their novel therapeutic potential. CONCLUSIONS: Our findings reveal A 2A R-D 2 R dimerization and βarr2-biased D 2 R signaling as novel and critical mechanisms for counteracting pathological CM hypertrophy and cardiac dysfunction. PDE10A acts as a pivotal negative regulator of this signaling axis. Targeting PDE10A, A 2A R-D 2 R/βarr2 signaling, or both offers potentially novel therapeutic strategies for combating pathological cardiac remodeling and cardiac dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphoric Diester HydrolasesMyocytes, CardiacCardiomegalyReceptors, Dopamine D2Receptor, Adenosine A2AAnimalsMiceSignal TransductionMice, KnockoutProtein MultimerizationMice, Inbred C57BLMaleCyclic AMP-Dependent Protein KinasesCyclic AMPHumansDisease Models, Animal

Stichwörter der Autor:innen

G protein-coupled receptorcardiac hypertrophycyclic nucleotidephosphodiesterase

Substanzen

Phosphoric Diester HydrolasesReceptors, Dopamine D2Receptor, Adenosine A2APde10a protein, mouseCyclic AMP-Dependent Protein KinasesCyclic AMP

Autor:innen und Institutionen

  • Departments of Medicine (S.C., X.F., S.X., N.Z., Z.J., C.Y.), University of Rochester School of Medicine and Dentistry, Rochester, NY.
  • Department of Biology, University of Rochester, NY (X.F., S.X., N.Z.).
  • Pathology and Laboratory Medicine (H.S.), University of Rochester School of Medicine and Dentistry, Rochester, NY.

ORCID-Profile: Si Chen, Hangchuan Shi, Zheng Gen Jin, Chen Yan

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Chen, S., Fan, X., Xu, S., Zhu, N., Shi, H., Jin, Z. G., & Yan, C. (2025). Role of A 2A R-D2R Dimerization and D 2 R-Biased Signaling in PDE10A-Mediated Cardiac Hypertrophy. Circulation. https://doi.org/10.1161/circulationaha.125.075465

Vancouver

Chen S, Fan X, Xu S, Zhu N, Shi H, Jin ZG, et al. Role of A 2A R-D2R Dimerization and D 2 R-Biased Signaling in PDE10A-Mediated Cardiac Hypertrophy. Circulation. 2025. doi:10.1161/circulationaha.125.075465

BibTeX
@article{Chen2025,
  author = {Chen, Si and Fan, Xinyue and Xu, Sumin and Zhu, Nichen and Shi, Hangchuan and Jin, Zheng Gen and Yan, Chen},
  title = {Role of A 2A R-D2R Dimerization and D 2 R-Biased Signaling in PDE10A-Mediated Cardiac Hypertrophy},
  journal = {Circulation},
  year = {2025},
  doi = {10.1161/circulationaha.125.075465}
}
Kostenlos starten →